These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38110548)

  • 1. Locked and loaded: targeting extracellular vesicles to preserve sight.
    Wooff Y
    Commun Biol; 2023 Dec; 6(1):1277. PubMed ID: 38110548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Perspectives on Delivery Systems Using Extracellular Vesicles in Neurological Disease.
    Tran PHL; Duan W; Lee BJ; Tran TTD
    Curr Pharm Des; 2020; 26(7):764-771. PubMed ID: 31894742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems.
    Lu M; Xing H; Xun Z; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Sci; 2018 Aug; 121():34-46. PubMed ID: 29733979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory Effect of Oxaliplatin-loaded Engineered Milk Extracellular Vesicles on Tumor Progression.
    Go G; Park HJ; Lee JH; Yun CW; Lee SH
    Anticancer Res; 2022 Feb; 42(2):857-866. PubMed ID: 35093883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles as antigen carriers for novel vaccination avenues.
    Mehanny M; Lehr CM; Fuhrmann G
    Adv Drug Deliv Rev; 2021 Jun; 173():164-180. PubMed ID: 33775707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles for targeted drug delivery: triumphs and challenges.
    Gudbergsson JM
    Future Med Chem; 2020 Jul; 12(14):1285-1287. PubMed ID: 32515217
    [No Abstract]   [Full Text] [Related]  

  • 9. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles as a next-generation drug delivery platform.
    Herrmann IK; Wood MJA; Fuhrmann G
    Nat Nanotechnol; 2021 Jul; 16(7):748-759. PubMed ID: 34211166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
    Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles from dHL-60 cells as delivery vehicles for diverse therapeutics.
    Kim JK; Youn YJ; Lee YB; Kim SH; Song DK; Shin M; Jin HK; Bae JS; Shrestha S; Hong CW
    Sci Rep; 2021 Apr; 11(1):8289. PubMed ID: 33859336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles in cancer nanomedicine.
    Tarasov VV; Svistunov AA; Chubarev VN; Dostdar SA; Sokolov AV; Brzecka A; Sukocheva O; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():212-225. PubMed ID: 31421263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoengineering facilitating the target mission: targeted extracellular vesicles delivery systems design.
    Song H; Chen X; Hao Y; Wang J; Xie Q; Wang X
    J Nanobiotechnology; 2022 Sep; 20(1):431. PubMed ID: 36175866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
    Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
    J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system.
    Jiang XC; Zhang T; Gao JQ
    Adv Drug Deliv Rev; 2022 Aug; 187():114324. PubMed ID: 35640803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression.
    Pi F; Binzel DW; Lee TJ; Li Z; Sun M; Rychahou P; Li H; Haque F; Wang S; Croce CM; Guo B; Evers BM; Guo P
    Nat Nanotechnol; 2018 Jan; 13(1):82-89. PubMed ID: 29230043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles for tumor targeting delivery based on five features principle.
    Yong T; Wang D; Li X; Yan Y; Hu J; Gan L; Yang X
    J Control Release; 2020 Jun; 322():555-565. PubMed ID: 32246977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.